Pharmacists in Freedom, Pennsylvania


31 Pharmacists found in Freedom
female pharmacist

Julie C. Allen


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

female pharmacist

Kathleen Prell


Pharmacist
1440 Harvey Run Rd, Freedom, PA 15042
724-462-9519    

male pharmacist

Kevin Undzius


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
844-259-1892    



male pharmacist

Kevin Samuel Gierlach


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
724-683-3710    

female pharmacist

Krista Lauck, PHARMD


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

female pharmacist

Ms. Nancy Springer, RPH



2500 Lovi Rd, Freedom, PA 15042
724-683-3710     724-683-3711

female pharmacist

Norenne Cole


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

female pharmacist

Patricia L Baker


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
724-683-3710     724-683-3711

female pharmacist

Dr. Rebecca Clarke


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

male pharmacist

Robert Joseph Lawlor, RPH


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

male pharmacist

Robert Cutlip, PHARMD


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    

female pharmacist

Samantha Harpel


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1420    

female pharmacist

Susan Lutz, RPH


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
844-259-1892    

male pharmacist

Thomas Michaels, PHARMD


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1420    

female pharmacist

Tracy Notarianni, RPH


Pharmacist
2500 Lovi Rd, Freedom, PA 15042
412-203-1444    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.